Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma

BACKGROUND: The aim of this investigation is to evaluate the association and potential mechanism between plasminogen activator urokinase (PLAU) and the prognosis of patients with liver hepatocellular carcinoma (LIHC). METHODS: We verified PLAU expression and its correlation with LIHC patients’ progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jiebin, Sun, Min, Li, Zhizhen, Shen, Yang, Wu, Yingjun, Zhang, Hesong, Xu, Zhichao, Gao, Qingxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331755/
https://www.ncbi.nlm.nih.gov/pubmed/37435232
http://dx.doi.org/10.21037/jgo-23-311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331755/
https://www.ncbi.nlm.nih.gov/pubmed/37435232
http://dx.doi.org/10.21037/jgo-23-311

Ejemplares similares